Latest news
NeuroThera Launches Phase IIb Trial at Yale for Novel Tourette Treatment - citybuzz -citybuzz - · Thu, 06 Aug 2026 00:24:05 GMTNeuroThera Labs Launches Phase IIb Clinical Trial at Yale Child Study Center for First-of-Its-Kind Treatment for Tourette Syndrome - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 12:48:44 GMTSciSparc’s NeuroThera Opens Yale Site for Phase IIb SCI-110 Tourette Syndrome Trial - Quiver QuantitativeQuiver Quantitative · Wed, 05 Aug 2026 12:30:00 GMTTourette drug candidate enters Phase IIb with prior 21% tic reduction - Stock TitanStock Titan · Wed, 05 Aug 2026 12:22:00 GMTEvommune begins Phase IIb trial of EVO756 for migraine - clinicaltrialsarena.comclinicaltrialsarena.com · Fri, 31 Jul 2026 10:52:13 GMTEstrella activates new site in Texas for STARLIGHT-1 Phase I/II trial - clinicaltrialsarena.comclinicaltrialsarena.com · Thu, 30 Jul 2026 11:05:47 GMTAbelZeta Receives FDA Clearance of Registrational Phase II Trial for C-CAR168 in Refractory Lupus Nephritis - PR NewswirePR Newswire · Mon, 27 Jul 2026 07:00:00 GMT